As the CEO and co-founder of QRGenetics, I bring a unique blend of firsthand experience, entrepreneurial spirit, and a deep passion for revolutionizing drug discovery. Stemming from the groundbreaking technology developed during my Ph.D. and postdoctoral studies, I've successfully raised two rounds of funding and secured numerous grants to fuel our research and development endeavors.My career has been dedicated to pushing the boundaries of innovation and precision in medicine, with a focus on utilizing cutting-edge AI-based systems to expedite the identification of novel drug-target combinations. I am driven by a relentless commitment to addressing the challenges posed by genetic diseases, particularly those lacking treatment options or with unknown mechanisms of action.At QRGenetics, we are leading the charge in revolutionizing drug discovery and pioneering efforts to bring precision medicine to a broader population. Through our powerful AI-supported drug discovery system, we are driving rapid advancements in the field and identifying new applications for expiring drugs.